Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905279 · ClinicalTrials.gov registry record · NA
Spider Phobia Opposite Action Treatment Study
A NA study, sponsored by University of Texas at Austin.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02905279 is a NA study that was terminated before completion, run by University of Texas at Austin. The registered enrollment target is 44 participants.
The verdict
NCT02905279, a NA study, was terminated before completion, sponsored by University of Texas at Austin.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study tests the effectiveness of exposure therapy for fear of spiders as enhanced by the use of antagonistic or opposite actions during treatment. The goal of the study is to compare the efficacy threat-relevant opposite actions and threat-irrelevant opposite actions in extinguishing fear.
Interventions
- BEHAVIORAL Exposure Therapy
- BEHAVIORAL Biofeedback Relaxation Training
- BEHAVIORAL Exposure with Threat-Relevant Opposite Actions
- BEHAVIORAL Exposure with Threat-Irrelevant Opposite Actions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2017-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02905279
The ClinicalTrials.gov registry entry for NCT02905279 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Exposure Therapy is the first listed.
NCT02905279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02905279 about?
NCT02905279 is a clinical study titled "Spider Phobia Opposite Action Treatment Study". This study tests the effectiveness of exposure therapy for fear of spiders as enhanced by the use of antagonistic or opposite actions during treatment. The goal of the study is to compare the efficacy threat-relevant opposite actions and threat-irrelevant opposite actions in extinguishing fear.
What is the current status of trial NCT02905279?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2016-06-01. Estimated completion is 2017-12-12.
What interventions are being tested in trial NCT02905279?
The interventions under investigation include: Exposure Therapy (BEHAVIORAL), Biofeedback Relaxation Training (BEHAVIORAL), Exposure with Threat-Relevant Opposite Actions (BEHAVIORAL), Exposure with Threat-Irrelevant Opposite Actions (BEHAVIORAL).
Who is sponsoring clinical trial NCT02905279?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.